SCHEMBL3417262

SCHEMBL3417262

COc1c(Cl)cc(Cl)cc1C(Br)C=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
CYP1A2 P05177 4/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CYP2C9 P11712 1/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
TPMT P51580 1/20 0.33
GAA P10253 1/20 0.33
ERN1 O75460 1/20 0.33
MAPT P10636 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5766175 0.77
SCHEMBL12974084 0.74 GABRA1 (0.48) KMT2ACYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL3415192 0.74 ERN1 (0.32) ALDH1A1ERN1TDP1
SCHEMBL3637979 0.73 ALDH1A1 (0.40) KMT2AALDH1A1KDM4EHPGDL3MBTL1
SCHEMBL3979239 0.72 ERN1 (0.39) KMT2AALDH1A1HPGDTSHRHSD17B10
SCHEMBL20445958 0.71 GAA (0.43) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL54507 0.71 KMT2A (0.47) KMT2ACYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL20550917 0.70 HTR2A (0.40) CYP1A2CYP2C19ALDH1A1CA1CA2
SCHEMBL20551547 0.70 HTT (0.42) CYP2D6ALDH1A1CA1CA2ERN1
SCHEMBL8813549 0.70 KMT2A (0.35) KMT2ACYP1A2CYP2D6CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265606-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2010-12-29 EP disclosed
WO-2009129109-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-22 WO disclosed